Story perspectives

FDA Director Suspended Amid Controversy Over Drug Approval Program

11/2/2025

48 5

Summary

Story summary

George Tidmarsh, director of the FDA's Center for Drug Evaluation and Research, was placed on administrative leave after raising concerns about a new program for rapid drug approvals.
Tidmarsh said the program undermines scientific standards and injects politics into the review process.
He faced allegations of misusing his authority against a former associate, leading to an investigation.
Tidmarsh denied wrongdoing and viewed the inquiry as retaliation.

1 of 1

Story summary

George Tidmarsh, director of the FDA's Center for Drug Evaluation and Research, was placed on administrative leave after raising concerns about a new program for rapid drug approvals.
Tidmarsh said the program undermines scientific standards and injects politics into the review process.
He faced allegations of misusing his authority against a former associate, leading to an investigation.
Tidmarsh denied wrongdoing and viewed the inquiry as retaliation.